Diary - News
All news Valbiotis succeeds in the industrial production of VALEDIA, in collaboration with the Pierre Fabre group
La Rochelle, 28 May 2019 (5:40 CEST) – VALBIOTIS FR0013254851 – ALVAL / PEA/SME eligible), a French Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, announces the successful industrial production of VALEDIA® (active substance TOTUM-63), the most advanced product in the VALBIOTIS portfolio. This achievement is the result of a collaboration with the Pierre Fabre group, a world-renowned expert in the industrial production of plant-based
active substances.